Primary Immunoglobulin A Nephropathy Igan clinical trials

Explore recruiting primary immunoglobulin a nephropathy igan clinical trials.

Recruiting primary immunoglobulin a nephropathy igan studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary Immunoglobulin A Nephropathy Igan trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Open-Label, Single-Arm, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Ravulizumab in Pediatric Participants (2 to < 18 years of age) with Primary Immunoglobulin A Nephropathy (IgAN)

Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants with Primary IgA Nephropathy in Combination with Stable Background Therapy

Spain, Czechia, Austria, Hungary, Germany, Norway +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Spain, Hungary

Human Pharmacology (Phase I)- Other EU CTIS Study details

Primary Immunoglobulin A Nephropathy Igan trials by city

Primary Immunoglobulin A Nephropathy Igan in Toronto Primary Immunoglobulin A Nephropathy Igan in Vancouver Primary Immunoglobulin A Nephropathy Igan in Montreal Primary Immunoglobulin A Nephropathy Igan in Calgary Primary Immunoglobulin A Nephropathy Igan in Edmonton Primary Immunoglobulin A Nephropathy Igan in Ottawa Primary Immunoglobulin A Nephropathy Igan in Winnipeg Primary Immunoglobulin A Nephropathy Igan in Quebec City Primary Immunoglobulin A Nephropathy Igan in Hamilton Primary Immunoglobulin A Nephropathy Igan in Kitchener Primary Immunoglobulin A Nephropathy Igan in London Primary Immunoglobulin A Nephropathy Igan in Halifax Primary Immunoglobulin A Nephropathy Igan in New York Primary Immunoglobulin A Nephropathy Igan in Los Angeles Primary Immunoglobulin A Nephropathy Igan in Chicago Primary Immunoglobulin A Nephropathy Igan in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease